Severino Beatrice Ulloa, Fuks David, Lainas Panagiotis, Blain Antoine, Validire Pierre, Ferraz Jean-Marc, Perniceni Thierry, Gayet Brice
Department of Digestive Disease, Institut Mutualiste Montsouris, Université Paris-Descartes, Paris, France.
Department of Pathology, Institut Mutualiste Montsouris, Université Paris-Descartes, Paris, France.
J Minim Access Surg. 2016 Apr-Jun;12(2):148-53. doi: 10.4103/0972-9941.169955.
Laparoscopic resection (LR) offers significant advantages compared to open resections for gastric gastrointestinal stromal tumours (GISTs). We aimed to evaluate whether LR outcomes jeopardised short and long-term outcomes of patients with large GISTs.
Among 50 patients undergoing surgery for gastric GISTs, 12 underwent LR for large GISTs (>5 cm). Their characteristics, perioperative results and survival were retrospectively compared to those of 22 patients who underwent LR for 'small GIST'.
The two groups were similar regarding demographics, rate of wedge resection and mean blood loss. No patient required transfusion or conversion. Operative time was significantly increased in the 'large GIST' group (160 min vs 112 min, P = 0.001). Mean tumour size was significantly lower in the 'small GIST' group (8.4 cm vs 2.4 cm, P = 0.0001). Resection margins were negative. The mortality rate was nil and the overall morbidity rates was similar in both groups. Median length of hospital stay was significantly increased in the 'large GIST' group (7 days vs 5 days, P = 0.004). Median follow-up was 47 months and one patient in the 'small GIST' group developed recurrence and died during follow-up 11 years after surgery. No patient died during follow-up.
LR for large GISTs is safe and technically feasible and does not negatively influence the oncologic course. Prospective randomised trials should be performed before using this approach in routine surgical care.
与开放性切除术相比,腹腔镜切除术(LR)治疗胃胃肠道间质瘤(GIST)具有显著优势。我们旨在评估LR治疗大GIST患者的短期和长期结局是否会受到影响。
在50例行胃GIST手术的患者中,12例因大GIST(>5 cm)接受了LR。将他们的特征、围手术期结果和生存率与22例因“小GIST”接受LR的患者进行回顾性比较。
两组在人口统计学、楔形切除率和平均失血量方面相似。无患者需要输血或中转开腹。“大GIST”组的手术时间显著延长(160分钟对112分钟,P = 0.001)。“小GIST”组的平均肿瘤大小显著更小(8.4 cm对2.4 cm,P = 0.0001)。切缘阴性。两组的死亡率均为零,总体发病率相似。“大GIST”组的中位住院时间显著延长(7天对5天,P = 0.004)。中位随访时间为47个月,“小GIST”组有1例患者在术后11年的随访期间出现复发并死亡。随访期间无患者死亡。
LR治疗大GIST是安全且技术可行的,对肿瘤学进程无负面影响。在将这种方法应用于常规手术治疗之前,应进行前瞻性随机试验。